Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Public Health ; 234: 98-104, 2024 Jul 06.
Article in English | MEDLINE | ID: mdl-38972230

ABSTRACT

OBJECTIVES: To estimate the size of COVID-19 waves using four indicators across three pandemic periods and assess potential surveillance bias. STUDY DESIGN: Case study using data from one region of Switzerland. METHODS: We compared cases, hospitalizations, deaths, and seroprevalence during three periods including the first three pandemic waves (period 1: Feb-Oct 2020; period 2: Oct 2020-Feb 2021; period 3: Feb-Aug 2021). Data were retrieved from the Federal Office of Public Health or estimated from population-based studies. To assess potential surveillance bias, indicators were compared to a reference indicator, i.e. seroprevalence during periods 1 and 2 and hospitalizations during the period 3. Timeliness of indicators (the duration from data generation to the availability of the information to decision-makers) was also evaluated. RESULTS: Using seroprevalence (our reference indicator for period 1 and 2), the 2nd wave size was slightly larger (by a ratio of 1.4) than the 1st wave. Compared to seroprevalence, cases largely overestimated the 2nd wave size (2nd vs 1st wave ratio: 6.5), while hospitalizations (ratio: 2.2) and deaths (ratio: 2.9) were more suitable to compare the size of these waves. Using hospitalizations as a reference, the 3rd wave size was slightly smaller (by a ratio of 0.7) than the 2nd wave. Cases or deaths slightly underestimated the 3rd wave size (3rd vs 2nd wave ratio for cases: 0.5; for deaths: 0.4). The seroprevalence was not useful to compare the size of these waves due to high vaccination rates. Across all waves, timeliness for cases and hospitalizations was better than for deaths or seroprevalence. CONCLUSIONS: The usefulness of indicators for assessing the size of pandemic waves depends on the type of indicator and the period of the pandemic.

2.
Compr Psychiatry ; 130: 152457, 2024 04.
Article in English | MEDLINE | ID: mdl-38325041

ABSTRACT

Previous mental health trajectory studies were mostly limited to the months before access to vaccination. They are not informing on whether public mental health has adapted to the pandemic. The aim of this analysis was to 1) investigate trajectories of monthly reported depressive symptoms from July 2020 to December 2021 in Switzerland, 2) compare average growth trajectories across regions with different stringency phases, and 3) explore the relative impact of self-reported worries related to health, economic and social domains as well as socio-economic indicators on growth trajectories. As part of the population-based Corona Immunitas program of regional, but harmonized, adult cohorts studying the pandemic course and impact, participants repeatedly reported online to the DASS-21 instrument on depressive symptomatology. Trajectories of depressive symptoms were estimated using a latent growth model, specified as a generalised linear mixed model. The time effect was modelled parametrically through a polynomial allowing to estimate trajectories for participants' missing time points. In all regions level and shape of the trajectories mirrored those of the KOF Stringency-Plus Index, which quantifies regional Covid-19 policy stringency. The higher level of average depression in trajectories of those expressing specific worries was most noticeable for the social domain. Younger age, female gender, and low household income went along with higher mean depression score trajectories throughout follow-up. Interventions to promote long-term resilience are an important part of pandemic preparedness, given the observed lack of an adaptation in mental health response to the pandemic even after the availability of vaccines in this high-income context.


Subject(s)
COVID-19 , Depression , Adult , Humans , Female , Depression/diagnosis , Depression/epidemiology , Depression/psychology , COVID-19/epidemiology , Pandemics , Switzerland/epidemiology , Anxiety
3.
Paediatr Anaesth ; 14(9): 774-7, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15330961

ABSTRACT

Tracheal agenesis is a potentially lethal congenital anomaly, appearing only at birth. We describe a newborn preterm infant who presented with immediate respiratory distress and no audible cry. There was almost complete tracheal agenesis with a very short segment of distal trachea (only two tracheal rings) arising from the anterior wall of the esophagus, before dividing into the mainstem bronchi. The anomaly was unsuspected prenatally, as the scan showed pyloric atresia and complex congenital cardiac disease. Despite the patient's difficult course, with correction of the rare-associated malformations (cardiac and gastrointestinal tract anomalies), the fact that the child is lively and neurologically normal for her age, requires that we now consider the patency of the airway and the possibility of surgical correction, in accordance with a good quality of life.


Subject(s)
Abnormalities, Multiple , Digestive System Surgical Procedures/methods , Respiratory System Abnormalities/diagnosis , Trachea/abnormalities , Tracheoesophageal Fistula/diagnosis , Tracheostomy/methods , Cardiac Catheterization , Cardiac Surgical Procedures , Catheterization , Digestive System Abnormalities/diagnosis , Digestive System Abnormalities/surgery , Esophagus/abnormalities , Esophagus/surgery , Female , Follow-Up Studies , Heart Defects, Congenital/diagnostic imaging , Heart Defects, Congenital/surgery , Humans , Imaging, Three-Dimensional , Infant , Larynx/diagnostic imaging , Rare Diseases , Respiratory System Abnormalities/surgery , Stents , Tomography, X-Ray Computed , Tracheoesophageal Fistula/surgery , Ultrasonography
4.
J Chem Inf Comput Sci ; 16(3): 128-30, 1976 Aug.
Article in English | MEDLINE | ID: mdl-1010857

ABSTRACT

This paper describes collaborative efforts between the National Cancer Institute (NCI) and the National Library of Medicine) (NLM) for the development of a new data base called CANCERLINE. The scope content, and future enhancements of this on-line file are discussed, as well as the plans for its use to disseminate cancer-related information via NLM's biomedical communications network.


Subject(s)
Information Systems , Neoplasms , Online Systems , National Institutes of Health (U.S.) , National Library of Medicine (U.S.) , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...